Rapidly progressive IgA nephropathy

被引:1
作者
Kobayashi N. [1 ]
Nishida M. [1 ,3 ]
Aoyama M. [2 ]
Yokoi K. [2 ]
Yahata T. [1 ]
Oka T. [1 ]
Sakata K. [1 ]
Shiraishi I. [1 ]
Itoi T. [1 ]
Hamaoka K. [1 ]
机构
[1] Dept. of Pediat. Cardiol./Nephrology, Kyoto Pref. University of Medicine, Graduate School of Medical Science, Kyoto
[2] Department of Pediatrics, Kyoto Pref. University of Medicine, Graduate School of Medical Science, Kyoto
[3] Dept. Pediat. Cardiol. Nephrology, Kyoto Pref. University of Medicine, Graduate School of Medical Science, Kamigyo-ku
关键词
Acute renal failure; Diffuse crescentic glomerulonephritis; IgA nephropathy; Rapidly progressive glomerulonephritis;
D O I
10.1007/BF02859270
中图分类号
学科分类号
摘要
A 14-year-old boy presented with macroscopic hematuria and a rapid deterioration in renal function. Percutaneous renal biopsy demonstrated severe crescentic IgA nephropathy (IgAN) with extensive (88%) glomerular crescent formation. After started intravenous administration of high-dose pulse methylprednisolone, severe nausea and general malaise accompanied by a rapid increase in Blood Urea Nitrogen (BUN) and serum creatinine levels appeared, however, the renal function ameliorated rapidly and fully recovered by following oral administration of corticosteroid. The clinical presentation of our case seems to be very remarkable compared to previously reported cases of rapidly progressive IgAN.
引用
收藏
页码:257 / 260
页数:3
相关论文
共 11 条
  • [1] Yoshikawa N., Ito H., Yoshihara S., Et al., Clinical course of IgA nephropathy in children, J Pediatr, 110, pp. 555-560, (1987)
  • [2] Martini A., Magrini U., Scelsi M., Capelli V., Barberis L., Chronic mesangioproliferative IgA glomerulonephritis complicated by a rapidly progressive course in a 14-year-old boy, Nephron, 29, pp. 164-166, (1981)
  • [3] Welch T.R., McAdams A.J., Berry A., Rapidly progressive IgA nephropathy, Am J Dis Child, 142, pp. 789-793, (1988)
  • [4] Yamazaki H., Mori A., Nomura Y., Et al., A case of rapidly progressive IgA nephropathy with transient hypocomplementemia at onset, Jpn J Nephrol, 39, pp. 765-770, (1997)
  • [5] Jindal K.K., Management of idiopathic crescentic and diffuse proliferative glomerulonephritis: Evidence-based recommendations, Kidney Int, 55, (1999)
  • [6] Cole B.R., Brocklebank J.T., Kienstra R.A., Kissane J.M., Robson A.M., Pulse" methylprednisolone therapy in the treatment of severe glomerulonephritis, J Pediatr, 88, pp. 307-314, (1976)
  • [7] Bolton W.K., Sturgill B.C., Methylpredonisolone therapy for acute crescentic rapidly progressive glomerulonephritis, Am J Nephrol, 9, pp. 368-375, (1989)
  • [8] Bolton W.K., Treatment of glomerular diseases: ANCA-negative RPGN, Semin Nephrol, 20, pp. 244-255, (2000)
  • [9] Itami N., Akutsu Y., Kusunoki Y., Tochimaru Y., Takekoshi Y., Does methylprednisolone pulse therapy deteriorate the course of rapidly progressive IgA nephropathy?, Am J Dis Child, 143, pp. 441-442, (1989)
  • [10] Sakemi T., Yamaguchi M., Fujimi S., Et al., Effects of the methylprednisolone pulse therapy on renal function, Am J Nephrol, 11, pp. 48-53, (1991)